Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Francoise Bernaudin, MD, Azadeh Djavidi, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Isabelle Hau, MD, Corinne Pondarré, MD PhD, Jean-Paul Vernant, MD, Mathieu Kuentz, MD, Nathalie Dhedin, MD, Jean-Hugues Dalle, MD PhD, Eliane Gluckman, Gerard Socie, MD PhD

Blood (2019) 134 (Supplement_1): 2253.

https://doi.org/10.1182/blood-2019-125316

Published: 2019

Journal Articles

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD

Gérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Dominique Bron, Philippe Gard, Zakaria Medeghri, Philippe Lehert, Chinglin Lai, Tim Corn, Jean-Paul Vernant

Blood (2017) 129 (5): 643–649.

https://doi.org/10.1182/blood-2016-09-738625

Published: 2017

Includes: Supplemental data

Journal Articles

Bronchiolitis Obliterans Occurring after Allogenic Hematopoietic Stem Cell Transplant: Comparison of Outcome Between Patients Equipped or Not with Home Spirometry Monitoring

Clémence Loiseau, Francois Lemonnier, MD, Odile Randrianarivelo, MD, Raphael Itzykson, MDPhD, Marie Hélène Becquemin, MD, Stephanie Nguyen Quoc, MDPhD, Madalina Uzunov, MD, Emilie Catherinot, MD, Elisabeth Rivaud, MD, Laurent Sutton, MD, Jean-Paul Vernant, MD, Louis Jean Couderc, MD, Nathalie Dhedin, MD

Blood (2015) 126 (23): 3161.

https://doi.org/10.1182/blood.V126.23.3161.3161

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma (WM/LPL). a Risk Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Working Party

Charalampia Kyriakou, MD PhD Consultant Haematologist, Ariane Boumendil, Herve Finel, Jean-Paul Vernant, Jan J. Cornelissen, MD PhD, Catherine Thieblemont, MD PhD, Patrice Chevallier, MD PhD, Rose-Marie Hamladji, Ghulam J Mufti, FRCP, FRCPath, MD, Patrizio Mazza, Pierre Zachee, MD PhD, Dietger Niederwieser, MD, Anna Sureda, Silvia Montoto, MD, Peter Dreger, MD

Blood (2014) 124 (21): 678.

https://doi.org/10.1182/blood.V124.21.678.678

Published: 2014

Journal Articles

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Miguel Hie, Julie Gay, Lionel Galicier, François Provôt, Claire Presne, Pascale Poullin, Guy Bonmarchand, Alain Wynckel, Ygal Benhamou, Philippe Vanhille, Aude Servais, Dominique Bordessoule, Jean-Philippe Coindre, Mohamed Hamidou, Jean-Paul Vernant, Agnès Veyradier, Paul Coppo, the French Thrombotic Microangiopathies Reference Centre

Blood (2014) 124 (2): 204–210.

https://doi.org/10.1182/blood-2014-01-550244

Published: 2014

Includes: Supplemental data

Journal Articles

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Blood (2014) 123 (24): 3739–3749.

https://doi.org/10.1182/blood-2014-01-547695

Published: 2014

Includes: Supplemental data

Journal Articles

Cardiac Toxicity Of High Dose Cyclophosphamide Post T Cell Replete HLA Haploidentical Hematopoietic Stem Cell Transplantation

Laetitia Souchet, MD, Julien Mayaux, MD, Damien Roosweil, MD, Madalina Uzunov, M.D., Alfred Le, Charles-Edouard Luyt, MD, Jean Paul Vernant, MD, Françoise Norol, MD, Hélène Treberden-Negre, MD, Nabih Azar, MD, Bénédicte Lebrun-Vigne, Delphine Callot, Ali Boudifa, Veronique Leblond, MD, Stéphanie Nguyen

Blood (2013) 122 (21): 5457.

https://doi.org/10.1182/blood.V122.21.5457.5457

Published: 2013

Journal Articles

The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Mathilde Lamarque, MD, Véronique Leblond, MD, PhD, Bruno R. Varet, MD, Sylvain Choquet, MD, Jean Paul Vernant, MD, Richard Delarue, MD, Bertrand Godeau, MD, Olivier Hermine, MD, PhD, Marc Michel, IV

Blood (2013) 122 (21): 2193.

https://doi.org/10.1182/blood.V122.21.2193.2193

Published: 2013

Journal Articles

Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center

Miguel HIE, MD, Julie Gay, MD, Lionel Galicier, MD, Francois Provot, Sandrine Malot, Pascale Poullin, MD, Guy Bonmarchand, MD, Alain Wynckel, MD, Ygal Benhamou, MD, Philippe Vanhille, Dominique Bordessoule, MD, PhD, Jean-Paul Vernant, Agnes Veyradier, MD PhD, Paul Coppo, MD PhD

Blood (2013) 122 (21): 448.

https://doi.org/10.1182/blood.V122.21.448.448

Published: 2013

Journal Articles

Prediction of Relapse and Impact of Immunomodulation Based On Quantitative RT-PCR of Insertion/Deletion Polymorphism for Chimerism Analysis in Acute Leukemia

Nathalie Jacque, MD, Stephanie Nguyen, MD, Jean Louis Golmard, Alice Garnier, MD, Madalina Uzunov, M.D., Veronique Leblond, Jean Paul Vernant, Dominique Bories, Nathalie Dhedin, MD

Blood (2012) 120 (21): 1966.

https://doi.org/10.1182/blood.V120.21.1966.1966

Published: 2012

Journal Articles

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Blood (2012) 120 (21): 1975.

https://doi.org/10.1182/blood.V120.21.1975.1975

Published: 2012

Journal Articles

Ex Vivo Expansion Reduces Neutropenia Post Autologous Transplantation of Peripheral Blood Hematopoïetic Stem Cells in Patients with Follicular Lymphoma. A Randomized, Double Blind Trial,

Helene Trebeden-Negre, Sylvain Choquet, MD, Michelle Rozenzwajg, Nabih Azar, MD, Francois Lefrère, MD, Farhad Heshmati, Laurent Sutton, Delphine Desjardins, David Klatzmann, Veronique Leblond, Jean Paul Vernant, Françoise Norol

Blood (2011) 118 (21): 4009.

https://doi.org/10.1182/blood.V118.21.4009.4009

Published: 2011

Journal Articles

The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party

Blood (2011) 118 (21): 502.

https://doi.org/10.1182/blood.V118.21.502.502

Published: 2011

Journal Articles

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Blood (2011) 118 (21): 3077.

https://doi.org/10.1182/blood.V118.21.3077.3077

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT.

Patrice Chevallier, MD, Myriam Labopin, MD, Jan J. Cornelissen, MD, PhD, Gérard Socié, Per T. Ljungman, MD, PhD, Bruno Lioure, Herve Tilly, MD, Alois Gratwohl, MD, Noel Milpied, MD, Ibrahim Yakoub-Agha, MD, PhD, Liisa Volin, Jean-Paul Vernant, Jacques-Olivier Bay, MD, PhD, Mauricette Michallet, Agnès Buzyn, MD, PhD, Benedicte Samey, Mohamad Mohty, Vanderson Rocha

Blood (2010) 116 (21): 4558.

https://doi.org/10.1182/blood.V116.21.4558.4558

Published: 2010

Journal Articles

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Blood (2010) 116 (21): 3518.

https://doi.org/10.1182/blood.V116.21.3518.3518

Published: 2010

Journal Articles

Azacytidine (AZA) In Relapsed MDS and AML After Allogeneic Stem Cell Transplantation (allo-HSCT): Results of the French ATU Program.

Romain Guièze, Anne Jouinot, Raphael Itzykson, Sylvain Thepot, Thierry Guillaume, Valérie Coiteux, Sébastien Wittnebel, Stéphane de Botton, Caroline Dartigeas, Anne Sirvent, Pascal Turlure, Didier Bouscary, Marie Robin, Jean-Paul Vernant, Laurent Sutton, Francois Dreyfus, Jacques-Olivier Bay, Lionel Ades, Pierre Fenaux

Blood (2010) 116 (21): 1293.

https://doi.org/10.1182/blood.V116.21.1293.1293

Published: 2010

Journal Articles

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Blood (2009) 114 (22): 194.

https://doi.org/10.1182/blood.V114.22.194.194

Published: 2009

Journal Articles

Improved Survival for 149 First-Line Multiple Myeloma (MM) Patients (pts) Treated by Tandem Autologous (Auto)/Allogeneic (Allo) Stem Cell Transplantation (SCT) : Retrospective Study of the Société Française de Greffe de Moelle Thérapie Cellulaire (SFGM-TC).

Claire Fabre, Serge Koscielny, Jean-Luc Harousseau, Mohamad Mohty, Didier Blaise, Noël Milpied, Bernard Rio, Mauricette Michallet, Thierry Facon, Jean-Paul Vernant, Agnès Buzyn, Gérard Socié, Jean-Yves Cahn, Natacha Maillard, Jacques-Olivier Bay, Jean-Henri Bourhis

Blood (2009) 114 (22): 1188.

https://doi.org/10.1182/blood.V114.22.1188.1188

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Mohamad Mohty, MD, PhD, Jean-Paul Vernant, Ibrahim Yakoub-Agha, MD, PhD, Didier Blaise, MD, Gérard Socié, MD, Catherine Cordonnier, MD, Eric Deconinck, Jean-Henri Bourhis, François Guilhot, MD, Agnes Buzyn, Norbert Ifrah, MD, Denis Guyotat, MD, PhD, Jean-Luc Harousseau, Laurent Sutton, MD, Noel-Jean Milpied, MD, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 201.

https://doi.org/10.1182/blood.V114.22.201.201

Published: 2009

NARROW

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD

Bronchiolitis Obliterans Occurring after Allogenic Hematopoietic Stem Cell Transplant: Comparison of Outcome Between Patients Equipped or Not with Home Spirometry Monitoring

Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma (WM/LPL). a Risk Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Working Party

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Cardiac Toxicity Of High Dose Cyclophosphamide Post T Cell Replete HLA Haploidentical Hematopoietic Stem Cell Transplantation

The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center

Prediction of Relapse and Impact of Immunomodulation Based On Quantitative RT-PCR of Insertion/Deletion Polymorphism for Chimerism Analysis in Acute Leukemia

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Ex Vivo Expansion Reduces Neutropenia Post Autologous Transplantation of Peripheral Blood Hematopoïetic Stem Cells in Patients with Follicular Lymphoma. A Randomized, Double Blind Trial,

The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT.

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Azacytidine (AZA) In Relapsed MDS and AML After Allogeneic Stem Cell Transplantation (allo-HSCT): Results of the French ATU Program.

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Improved Survival for 149 First-Line Multiple Myeloma (MM) Patients (pts) Treated by Tandem Autologous (Auto)/Allogeneic (Allo) Stem Cell Transplantation (SCT) : Retrospective Study of the Société Française de Greffe de Moelle Thérapie Cellulaire (SFGM-TC).

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only